The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $5.26

Today's change-0.01 -0.19%
Updated August 30 4:02 PM EDT. Delayed by at least 15 minutes.
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $5.26

Today's change-0.01 -0.19%
Updated August 30 4:02 PM EDT. Delayed by at least 15 minutes.

China Cord Blood Corp down (U.S.)$0.01

China Cord Blood Corp closed lower Tuesday, dropping (U.S.)$0.01 or 0.19% to (U.S.)$5.26. Over the last five days, shares have gained 1.15%, but are down 17.43% for the last year to date. Shares have underperformed the S&P 500 by 30.79% during the last year.

Key company metrics

  • Open(U.S.) $5.26
  • Previous close(U.S.) $5.27
  • High(U.S.) $5.26
  • Low(U.S.) $5.20
  • Bid / Ask-- / --
  • YTD % change-17.43%
  • Volume72,767
  • Average volume (10-day)73,945
  • Average volume (1-month)51,252
  • Average volume (3-month)42,001
  • 52-week range(U.S.) $4.93 to (U.S.) $6.69
  • Beta0.56
  • Trailing P/E27.53×
  • P/E 1 year forward35.13×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.19
Updated August 30 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue173157169171
Total other revenue--------
Total revenue173157169171
Gross profit136122133134
Total cost of revenue37353637
Total operating expense121117119127
Selling / general / administrative81808080
Research & development2232
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0--8
Other operating expenses, total--------
Operating income52405144
Interest income (expense), net non-operating-29-28-28-26
Gain (loss) on sale of assets--------
Other--------
Income before tax28176432
Income after tax1685119
Income tax, total1291413
Net income1685019
Total adjustments to net income--------
Net income before extra. items1685019
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1685019
Inc. avail. to common incl. extra. items1685019
Diluted net income1685019
Dilution adjustment--------
Diluted weighted average shares73737373
Diluted EPS excluding extraordinary itemsvalue per share0.220.110.690.26
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share0.220.110.690.32